Rising Star Awards

Prostate Cancer Canada (PCC) is proud to debut the Rising Star in Prostate Cancer Research program, which provide salary and research support for outstanding research scientists initiating careers as independent investigators in prostate cancer research.

These awards provide the opportunity for research scientists within the first 5 years of their first academic or research appointment to develop and demonstrate independence in initiating and conducting prostate cancer research.

The proposed research project must be in the area of prostate cancer and may address any of the broad areas of prostate cancer research, including but not limited to:
  • prostate cancer biology
  • treatment
  • diagnosis
  • survivorship
  • prevention
The amount available for this program is subject to funds raised. The number of awards to be distributed is contingent upon availability of resources and the quality of applications received. The current plan is to distribute four awards with a maximum amount per award of $150,000 per year ($75,000 for salary support and $75,000 for research expenses) for up to 3 years.

For more details on this award, please click here.


2012 Rising Star in Prostate Cancer Research
Review Panel

If you are seeking clarifications, please refer to the FAQs prior to contacting PCC. The FAQs document will continue to be updated as questions are put forward.
Kim Chi, Co-chair
 

Anne-Marie Mes-Masson, Co-chair


Glenn Baumann


Inka Brockhausen


Ralph Buttyan


Gerardo Ferbeyre


Jacques Lapointe


Winston Isaac
Vancouver Prostate Centre
Vancouver, BC

Centre de recherché du Centre Hospitalier de l'Université de Montréal
Montreal, QC

University of Western Ontario
London, ON

Queen’s University
Kingston, ON

Vancouver Prostate Centre
Vancouver, BC

University of Montreal
Montreal, QC

McGill University Health Centre Research Institute
Montreal, QC

Lay member   
Brampton, ON

 

 





Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Mutation in prostate tumours shown to change epigenetic identity, the make-up of DNA

(TORONTO, Canada - Aug 7, 2017) -- Prostate cancer researchers have mapped the impact of an acquired mutation that alters epigenetic identity, the make-up of DNA, in about 50% of patient tumour samples.
More

Movember Foundation and Prostate Cancer Canada team up to turn research into results

July 26, 2017 - TORONTO, ON - Continuing their longstanding tradition of partnering to fund high quality Canadian prostate cancer research, Prostate Cancer Canada (PCC) and The Movember Foundation today announced two new projects with very real potential to make a tangible difference in the lives of men living with aggressive forms of prostate cancer.
More

Plaid for Dad participation skyrockets in third year

July 7, 2017 - TORONTO, ON - Launched for the first time in 2015, Prostate Cancer Canada's (PCC) Plaid for Dad campaign has further established itself as the way Canadians are choosing to give back on Father's Day weekend.
More


Click here for news archive